EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice

Eliot J Davidowitz iD, Patricia Lopez, Heidy Jimenez, Leslie Adrien, Peter Davies, James G Moe

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Eliot J Davidowitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oligomerix, Inc., White Plains, NY, United States of America. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, tau Proteins, Tauopathies. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in tau biology and the difficulties of amyloid-directed immunotherapeutics have heightened interest in tau as a target for small molecule drug discovery for neurodegenerative diseases. Here, we evaluated OLX-07010, a small molecule inhibitor of tau self-association, for the prevention of tau aggregation. The primary endpoint of the study was statistically significant reduction of insoluble tau aggregates in treated JNPL3 mice compared with Vehicle-control mice. Secondary endpoints were dose-dependent reduction of insoluble tau aggregates, reduction of phosphorylated tau, and reduction of soluble tau. This study was performed in JNPL3 mice, which are representative of inherited forms of 4-repeat tauopathies with the P301L tau mutation (e.g., progressive supranuclear palsy and frontotemporal dementia). The P301L mutation makes tau prone to aggregation; therefore, JNPL3 mice present a more challenging target than mouse models of human tau without mutations. JNPL3 mice were treated from 3 to 7 months of age with Vehicle, 30 mg/kg compound dose, or 40 mg/kg compound dose. Biochemical methods were used to evaluate self-associated tau, insoluble tau aggregates, total tau, and phosphorylated tau in the hindbrain, cortex, and hippocampus. The Vehicle group had higher levels of insoluble tau in the hindbrain than the Baseline group; treatment with 40 mg/kg compound dose prevented this increase. In the cortex, the levels of insoluble tau were similar in the Baseline and Vehicle groups, indicating that the pathological phenotype of these mice was beginning to emerge at the study endpoint and that there was a delay in the development of the phenotype of the model as originally characterized. No drug-related adverse effects were observed during the 4-month treatment period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative Diseasestau ProteinsTauopathiesAnimalsHumansMiceDisease Models, AnimalMice, TransgenicRhombencephalon

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Oligomerix, Inc., White Plains, NY, United States of America.
  • Oligomerix, Inc., Bronx, NY, United States of America.
  • The Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States of America.

ORCID-Profile: Eliot J Davidowitz

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Davidowitz, E. J., Lopez, P., Jimenez, H., Adrien, L., Davies, P., & Moe, J. G. (2023). Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0286523

Vancouver

Davidowitz EJ, Lopez P, Jimenez H, Adrien L, Davies P, Moe JG. Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice. PLOS ONE. 2023. doi:10.1371/journal.pone.0286523

BibTeX
@article{Davidowitz2023,
  author = {Davidowitz, Eliot J and Lopez, Patricia and Jimenez, Heidy and Adrien, Leslie and Davies, Peter and Moe, James G},
  title = {Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286523}
}
Kostenlos starten →